Comparison of a Novel Leuprolide With Market Leuprolide

Summary

This is a single dose, randomized, single blind, parallel group study to evaluate the testosterone suppressive effect in healthy male volunteers of a novel leuprolide acetate 3.75mg depot vs market reference leuprolide acetate 3.75mg depot. The safety, tolerability and the pharmacokinetic properties of the investigational drug and the control drug will also be assessed.

Timeline

Start

2018-08-01

Primary completion

2018-10

Completion

2018-12

Drugs

Indications